$American Virtual (AVCT.US)$ lfg shorts squeezing to 3$+ today easily.

Musk — who was named Time's Person of the Year this week — spoke about Bezos during an interview with the Financial Times published on Wednesday.
Musk said in the interview that while his fellow billionaire has "reasonably good engineering aptitude," he feels Bezos "does not seem to be willing to spend mental energy getting into the details of engineering."
"[He] does take himself a bit too seriously," he added of Bezos. "In some ways, I'm trying to goad him into spending more time at Blue Origin so they make more progress. As a friend of mine says, he should spend more time at Blue Origin and less time in the hot tub."
Musk's comments are just the latest in a 15-year feud between the two centibillionaires, which has intensified amid a growing rivalry between their rocket companies, SpaceX and Blue Origin. "Turns out Besos [sic] retired in order to pursue a full-time job filing lawsuits against SpaceX," Musk tweeted in August. Bezos as Amazon CEO in July.
Musk has repeatedly and publicly called Bezos a "copycat" — once after Amazon announced its plan to launch internet-beaming satellites, and again when Amazon acquired self-driving-taxi company Zoox.
While Bezos has stopped short of calling out Musk directly, he has taken aim at Musk's biggest ambition: colonizing Mars, the main goal of SpaceX. Bezos' focus is on getting humans to the moon, and he's described the idea of reaching Mars as "un-motivating." "Go live on the top of Mount Everest for a year first and see if you like it, because it's a garden paradise compared to Mars," Bezos said in 2019.
Musk may lead the most valuable carmaker on the planet but he doesn't act like it in the traditional sense. Unlike top executives as other firms, Musk regularly tweets out memes, juvenile jokes, and the occasional company update to his 66.5 million followers. He frequently engages with fans online and gets into spats with critics.
Bezos' public image, by comparison, is highly curated. He has3 million followers on Twitter and isn't prone to the same unfiltered musings and casual banter as Musk.
Mooers, do you like Musk more or Bezos? Prefer Mars more or the moon?
$Amazon (AMZN.US)$ $Tesla (TSLA.US)$
Source: Business Insider, People

A short squeeze can occur when a heavily shorted stock rises in value instead of falling. Short sellers could be looking to close out their position and can face a loss if they have to buy back the shares they initially borrowed at a higher price.
Here is a look at Fintel's top five short squeeze candidates for the week of Dec. 06.
$Pioneer Power Solutions (PPSI.US)$ $Nuzee (NUZE.US)$ $RenovoRx (RNXT.US)$ $Grab Holdings (GRAB.US)$ $Cortexyme (CRTX.US)$
Let's look for the next $GameStop (GME.US)$or $AMC Entertainment (AMC.US)$.

$American Virtual (AVCT.US)$ $17 PT, Healthy Financials (Assets > Liabilities, Increasing Revenues), Squeeze Candidate, Strong Partnerships Established, $11.5 Warrants, $9 Share offer on the table. Immense growth potential, once management sorts itself out this will be huge.

$Biofrontera (BFRI.US)$ lets break 7.3

$VYNE Therapeutics (VYNE.US)$ may be setting up for AH run. 
$American Virtual (AVCT.US)$  is a beast

Value or Growth Stocks? Lots of investors have long argued the dilemma. 
The so-called growth stocks have been through their hard time in recent days. High-flying growth stocks are bordering on correction territory. 
Familiar names like $Palantir (PLTR.US)$, $CrowdStrike (CRWD.US)$, $Snowflake (SNOW.US)$ $Salesforce (CRM.US)$ etc. 
When talking about disruptive innovation, the name that comes up to investors' mind must be "ARK". And it's been a dismal week for Cathie Wood's flagship fund, $ARK Innovation ETF (ARKK.US)$ , that's left nearly all of her holdings in bear market.
ARKK fell 12.6% this week for its worst week since February. It dropped 5.5% on Friday. 
Is this the sign that people are not in favor of growth stocks and disruptive innovation companies? Or maybe it's just because investors need something more solid fundamentally under the risk of Omicron? Would you comment down below and tell mooers about your thoughts?

$Pasithea Therapeutics (KTTA.US)$ did you see what $Biofrontera (BFRI.US)$  is doing. this will happen here as well sooner than you think. ketamine is revolutionary in treating depression, the fact they have set up new clinics in Florida and Nevada is just the beginning. also low float small market cap this will fly!